Related Experiment Video
Updated: Apr 14, 2026
14:37
Modeling an Enzyme Active Site using Molecular Visualization Freeware
Published on: December 25, 2021
12.0K
Three-dimensional Structure of a Kunitz-type Inhibitor in Complex with an Elastase-like Enzyme
Rossana García-Fernández1, Markus Perbandt2, Dirk Rehders3
1From the Centro de Estudio de Proteínas, Facultad de Biología, Universidad de la Habana, 20146 Habana, Cuba.
The Journal of Biological Chemistry
|April 17, 2015
Summary
Researchers modified a sea anemone inhibitor (ShPI-1) to target elastase-like enzymes, crucial in diseases like pancreatitis and cancer. Structural analysis revealed how this modified inhibitor binds, paving the way for new anti-elastase drugs.
Area of Science:
- Biochemistry
- Structural Biology
- Enzyme Inhibition
Background:
- Elastase-like enzymes are implicated in diseases including pancreatitis, lung inflammation, and cancer.
- Understanding enzyme-inhibitor interactions is key to developing novel therapeutic compounds.
- Kunitz-type inhibitors offer a scaffold, but their interaction with elastase-like enzymes needs structural elucidation.
Purpose of the Study:
- To enhance the selectivity of the sea anemone inhibitor ShPI-1 towards elastase-like enzymes.
- To structurally characterize the interaction between a modified ShPI-1 variant and porcine pancreatic elastase (PPE).
- To provide a structural basis for designing improved Kunitz-type inhibitors.
Main Methods:
- Site-directed mutagenesis of ShPI-1 to substitute the P1 residue (Lys13) with leucine, creating rShPI-1/K13L.
- Assay of inhibitory activity against elastase-like enzymes (PPE, human neutrophil elastase, chymotrypsin).
- X-ray crystallography to determine the complex structure of PPE·rShPI-1/K13L at 2.0 Å resolution.
Main Results:
- The variant rShPI-1/K13L demonstrated novel anti-PPE activity and enhanced inhibition of human neutrophil elastase and chymotrypsin.
- The crystal structure revealed the canonical interaction between a BPTI-Kunitz-type inhibitor and elastase-like enzymes.
- The P1 residue substitution and binding loop interactions significantly contribute to complex stability and selectivity.
Conclusions:
- The study provides the first structural insights into the interaction of BPTI-Kunitz-type inhibitors with elastase-like enzymes.
- The P3 site plays a crucial role in directing inhibitor selectivity against pancreatic and neutrophil elastases.
- Results offer a structural foundation for further mutagenesis to optimize inhibitor binding affinity and selectivity.
Related Concept Videos
02:34Enzymes
97.5K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
97.5K
01:13Induced-fit Model
92.2K
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
92.2K
01:30Enzyme Inhibition
95.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.3K
02:04Protein-protein Interfaces
15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
02:15Protein and Protein Structure
93.2K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
A protein's shape is critical to its function. For example, an enzyme...
93.2K
01:13Introduction to Mechanisms of Enzyme Catalysis
11.7K
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
11.7K